In silico modelling of microbial and human metabolism: a case study with the fungicide carbendazim by MOSTRAG-SZLICHTYNG A. & WORTH Andrew
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EUR 24523 EN  -  2010 
In silico modelling of microbial and human 
metabolism: a case study with the 
fungicide carbendazim 
Aleksandra Mostrag-Szlichtyng and Andrew P. Worth 
 
The mission of the JRC-IHCP is to protect the interests and health of the consumer in the 
framework of EU legislation on chemicals, food, and consumer products by providing scientific 
and technical support including risk-benefit assessment and analysis of traceability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
European Commission 
Joint Research Centre 
Institute for Health and Consumer Protection 
 
Contact information 
Address: Via E. Fermi 2749, 21027 Ispra (VA), Italy 
E-mail: andrew.worth@ec.europa.eu 
Tel.: +39 0332 789566 
Fax: +39 0332 786717 
 
http://ihcp.jrc.ec.europa.eu/ 
http://www.jrc.ec.europa.eu/ 
 
Legal Notice 
Neither the European Commission nor any person acting on behalf of the Commission is 
responsible for the use which might be made of this publication. 
 
Europe Direct is a service to help you find answers 
to your questions about the European Union 
 
Freephone number (*): 
00 800 6 7 8 9 10 11 
 
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. 
 
A great deal of additional information on the European Union is available on the Internet. 
It can be accessed through the Europa server http://europa.eu/ 
 
JRC60264 
 
EUR 24523 EN 
ISBN 978-92-79-16744-7 
ISSN 1018-5593 
doi:10.2788/98567 
 
Luxembourg: Publications Office of the European Union 
 
© European Union, 2010 
 
Reproduction is authorised provided the source is acknowledged 
 
Printed in Italy 
 
 ABSTRACT 
 
A major source of uncertainty when assessing the human health and environmental risks of chemicals 
is the paucity of experimental information on the metabolic and (bio)degradation pathways of parent 
compounds and the toxicological properties of their  metabolites and (bio)degradation products. Taking 
into account  animal welfare and  cost-effectiveness considerations, the only practical means of 
obtaining the information needed to reduce this uncertainty, is to use alternative (non-animal) methods, 
such as in vitro tests and in silico models.  
In this report, we explore the usefulness of in silico metabolic simulation tools (expert systems) as a 
means of supporting the regulatory assessment of chemicals. In particular, we investigate the use of 
selected in silico tools to: (i) simulate microbial and mammalian metabolic pathways; (ii) identify 
potential metabolites resulting from biotransformation; and (iii) gain insights into the mechanistic 
rationale of simulated metabolic reactions and the likelihood of their occurrence. For illustrative 
purposes, the  microbial and mammalian biotransformation pathways of a case study compound, the 
fungicide carbendazim, were generated by using the CRAFT Explorer 1.0 (Molecular Networks 
GmbH) and Meteor 12.0.0 (Lhasa Ltd.) software tools. Additionally, the set of potential metabolites 
resulting from microbial and mammalian metabolism was predicted with the OECD QSAR 
Application Toolbox 2.0 (beta version).  
Comparison of the in silico predictions with existing experimental data on carbendazim metabolism 
showed the potential usefulness of using software tools for metabolite prediction. However, the results 
are strongly dependent on the software constraints specified by the user, and require careful 
interpretation, taking into account the needs of the exercise and the availability of existing information. 
Further efforts are needed to develop guidance on the use of in silico metabolic simulation tools for the 
purposes of regulatory risk assessments. 
 
 LIST OF ABBREVIATIONS 
 
2-AB   2-Aminobenzimidazole 
5,6-DHCB  Methyl (5,6-dihydroxy-1H-benzimidazol-2-yl)carbamate 
5,6-DHCB-G  Glucuronic acid conjugate of methyl (5,6-dihydroxy-1H-  
  benzimidazol-  2-yl)carbamate 
5,6-DHCB-S  Sulphuric acid conjugate of Methyl (5,6-dihydroxy-1H-  
  benzimidazol-2-yl)carbamate 
5,6-DHHBC-G  S-[5,6-dihydro-5-hydroxy-2-(methoxycarbonylamino)-1H-  
  benzimidazol-6-yl]glutathione 
5,6-HOBC N-oxide  Methyl (5-hydroxy-6-oxo-6H-benzimidazol-2-yl)carbamate N1- 
  oxide 
5,6-HOBC N-oxide-G  Glucuronide of Methyl (5-hydroxy-6-oxo-6H-benzimidazol-2- 
  yl)carbamate N1-oxide 
5-HCB  Methyl 5-hydroxy-1H-benzimidazol-2-ylcarbamate 
5-HCB-G  Glucuronic acid conjugate of Methyl 5-hydroxy-1H-benzimidazol-2-
  ylcarbamate 
5-HCB-S  Sulphuric acid conjugate of Methyl 5-hydroxy-1H-benzimidazol-2-
  ylcarbamate 
AGES  Austrian Agency for Health and Food Safety 
Bt  Biotransformation 
CAS No  Chemical Abstracts Service Registry Number 
CRAFT  Chemical Reactivity and Fate Tool  
CYP450  Cytochrome P450 
EC  European Commission 
EEC  European Economic Community 
EFSA  European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organisation 
IUPAC  International Union of Pure and Applied Chemistry 
JMPR  Joint FAO/WHO Meeting on Pesticide Residues 
JRC  Joint Research Centre (of the European Commission) 
Log P  Octanol/Water partition coefficient 
M   Meteor 12.0.0 Metabolite 
OECD  Organisation for Economic Cooperation and Development 
P  CRAFT Explorer 1.0 (Bio)Degradation Product 
PPP  Plant Protection Product  
Q   Meteor 12.0.0 Query Compound 
QSAR  Quantitative Structure-Activity Relationship 
SA  Structural Alert 
SAR  Structure-Activity Relationship 
SMILES  Simplified Molecular Input Line Entry Specification 
TIMES  Tissue Metabolism Simulator 
TTC  Threshold of Toxicological Concern 
UGT  UDP-glucuronosyltransferase 
UM-BBD   University of Minnesota Biocatalysis and Biodegradation Database 
WHO  World Health Organisation
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1. Introduction 
One of the most important ways of protecting plants and plant products against harmful 
organisms and of improving agricultural production is the use of plant protection products 
(agricultural pesticides). However, a possible consequence of their use may be the presence of 
pesticide residues in the treated products. 
The broad application of plant protection products on food commodities results in the 
increased exposure of consumers, not only to the residues of the active components, but also 
to a wide range of their metabolites, degradation and reaction products. As the total burden of 
all toxicologically significant substances should be taken into account for human health and 
environmental risk assessments, data on metabolism in mammals, birds, livestock, plants, 
needed along with data on environmental fate (including microbial degradation in soil or 
water/sediment. In combination with toxicity data, this information provides a broad 
experimental basis for the risk assessment.  
Metabolism is one of the main factors influencing the fate and toxicity of chemicals. For 
instance, microbial metabolism (e.g. in soil or water) affects the overall environmental 
persistence of chemicals and the duration of their presence and potential activity in particular 
environmental compartments. On the other hand, biotransformations inside organisms (e.g. 
mammals), which generally convert xenobiotics into more polar and more easily excreted 
forms, regulate the internal exposure conditions. Metabolites that are not toxicologically 
significant can be excluded from further investigations. In some cases, however, the 
metabolites represent equal or higher toxicity than the parent compounds and these need to be 
considered to ensure that the risk assessment provides adequate protection of human health 
and the environment  
A major difficulty stems from the fact that only the toxicological properties of the active 
substance are normally directly investigated through the range of toxicological studies 
required according to legislation such as Directive 91/414/EEC (EC, 1991) in the European 
Union. However, according to the OECD guidance document on the definition of residue 
(OECD, 2009), all metabolites the consumer is exposed to in plant and animal commodities 
should be considered in terms of their relevance for risk assessment. In the case of metabolites 
present in food commodities that are also significant metabolites in rodent studies, their 
toxicity is considered to be implicitly assessed in the rodent study. Data gaps arise for 
metabolites that are not considered to be significantly present in rodents. Since further 
toxicological studies are restricted as far as possible to minimise the use of animals in 
toxicological testing, alternative (non-animal) methods need to be developed further and used 
to optimise the evaluation the toxicological profile of metabolites and degradates. For 
example, in silico methods that simulate metabolic and degradation reactions, and which 
predict ranges of potential (theoretically possible) metabolites/products, could be used to 
guide further toxicological assessments. The results obtained with these simulation methods 
could be applied in combination with Threshold of Toxicological Concern (TTC) 
considerations (EFSA, 2010a), existing knowledge on the impact of metabolic and 
degradation processes on pesticide residue toxicity (EFSA, 2010b), as well as in silico 
toxicity predictions (EFSA, 2010c). 
Several in silico approaches for modelling metabolism can be distinguished, e.g. statistical 
models (Okey & Stensel, 1996; Boethling, 1986), group contribution models (Tunkel et al., 
2000; Boethling et al., 1994) or models based on enzyme activity and substrate specificity 
(Vermulen, 2003). Models for predicting microbial metabolism (biodegradation) and 
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mammalian metabolism are reviewed in depth elsewhere (Pavan & Worth, 2008; Mostrag-
Szlichtyng & Worth, 2010). 
In this report, we explore the usefulness of in silico metabolic simulation tools (expert 
systems) as a means of supporting the regulatory assessment of chemicals. In particular, we 
investigate the use of selected in silico tools to: (i) simulate microbial and mammalian 
metabolic pathways; (ii) identify potential (theoretically possible) metabolites resulting from 
biotransformation; and (iii) gain insights into the mechanistic rationale of simulated metabolic 
reactions and the likelihood of their occurrence. 
For illustrative purposes, the microbial and mammalian biotransformation of a case study 
compound, the fungicide carbendazim, was performed by using the CRAFT Explorer 1.0 
(Molecular Networks GmbH, Germany) and Meteor 12.0.0 (Lhasa Ltd., UK) software tools. 
Additionally, the set of potential microbial and mammalian metabolites was predicted with 
the OECD QSAR Application Toolbox 2.0 (beta version), which implements the hybrid 
(statistical and rule-based) methodology to predict metabolism (Mekenyan et al., 2004). The 
results of the simulations were compared with existing experimental data on the mammalian 
metabolism of carbendazim in order to evaluate the applicability of the in silico tools. 
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2. Characteristics of the fungicide carbendazim 
Carbendazim was first included in Annex I of the Plant Protection Products Directive 
(Directive 91/414/EEC; EC, 1991) on 1 January 2007 by Commission Directive 
2006/135/EC, as amended by Commission Directive 2009/152/EC. Annex I is the list of 
active substances that are authorised for use in plant protection products within the European 
Union.  
Carbendazim was recently re-evaluated by the European Food Safety Authority (EFSA), 
following an industry request to the European Commission for renewal of the Annex I 
inclusion (which is due to expire on 31 December 2010). The conclusions of the EFSA peer 
review (EFSA, 2010d) identify a number of data gaps, including the route of aerobic 
biodegradation in soil. Thus, the possibility to model metabolite generation by aerobic 
biodegradation in soil (or water/sediment) could be useful in the assessment of fate. 
To explore the possibility of filling this data gap by using metabolic simulation tools, the 
CRAFT Explorer 1.0 software tool was used to simulate the biodegradation pathways of 
carbendazim and to generate a range of potential metabolites.   
Since the mammalian metabolism of carbendazim has been investigated extensively, existing 
experimental data could be used to assess the applicability of metabolism simulations 
performed in this study (i.e. Meteor 12.0.0 and OECD QSAR Application Toolbox 2.0) in this 
particular case.  
Carbendazim is the common name for methyl benzimidazol-2-ylcarbamate or 2-
(methoxycarbonylamino)-benzimidazole (IUPAC). The main information concerning its 
chemical identification as well as physical and chemical properties is provided in Table 1.  
Table 1. Chemical identity and physicochemical properties of carbendazim (EFSA, 2010d) 
 
Chemical name  
(IUPAC) 
 
Methyl benzimidazol-2-ylcarbamate 
(MBC);  
2-(Methoxycarbonylamino)-
benzimidazole 
Melting 
point  
 
 
 
302 – 307 °C (under decomposition) 
Chemical name  
(CA) 
Methyl 1H-benzimidazol-2-
ylcarbamate 
Boiling  
point  
 
Not applicable 
 
CAS No 
 
10605-21-7 
 
Appearance 
 
Pure: almost colourless crystalline solid,  
odourless; 
Technical: light yellow to light grey crystalline  
powder, odourless 
SMILES 
 
c12c(cccc1)N=C(NC(=O)OC)N2 
 
Vapour 
pressure 
9 x 10-5 Pa (20 °C);  
1.5 x 10-4 Pa (25 °C) 
Molecular  
formula 
C9H9N3O2 
 
Henry’s law 
constant 
3.6 x 10-3 Pa m3/mol (24 °C) 
 
Molecular mass 
 
191.21 g/mol 
 
Water 
Solubility  
 pH 4: 29 mg/L;  pH 7: 8 mg/L;  pH 8: 7 mg/L 
 
Partition  
coefficient 
 
 
 
pH 5: log PO/W  = 1.4 (25 °C);  
pH 7-9: log PO/W  = 1.5 (25 °C) 
 
 Structural formula  
 
  
Dissociation 
constant  
pKa = 4.2  
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Recently, EFSA identified data gaps for the following properties of carbendazim: UV spectra, 
solubility in organic solvents, dissociation constant, flammability, auto-flammability, 
explosive properties, oxidising properties and surface tension, soil photoloysis, route of 
aerobic degradation in soil (EFSA, 2010d).  
Carbendazim is a wide-spectrum systemic fungicide, belonging to the chemical class of 
highly selective benzimidazoles. It is used as plants (e.g. cereals, sugar beet, fodder beet, 
oilseed rape, maize, fruit and vegetables) disease controlling agent, effective against many 
ascomycetes, basidiomycetes and deuteromycetes. It can be applied to prevent either crops (in 
pre- and postharvest treatment) or stored postharvest food (EFSA, 2010b; Magnucka et al., 
2007).  
The mode of action of benzimidazoles relies on intensive binding to fungal microtubules 
(tubulin ß-subunit) and disrupting various cellular processes (e.g. formation of the mitotic 
spindle, nuclear division, cytoskeleton formation), resulting in the cells death. The selective 
toxicity of benzimidazole fungicides and their relative potency towards different organism 
varies widely and is highly dependent on the structure of both the chemical and the respective 
tubulin, as well as on the fact that benzimidazoles show enhanced affinity to fungal 
microtubules. Nevertheless, their presence in other eukaryotes can also cause adverse effects 
on cellular functions. Benzimidazoles can initiate chromosomal aberrations, changes in 
chloroplasts (and, thus, photosynthesis), in germination and growth of seedlings. They may 
also impair other physiological processes and modify plant cells metabolism as well as 
contribute to morphological changes in plants (EFSA, 2010b; Magnucka et al., 2007; Kiso et 
al., 2004; Bilinski et al., 1984). The fact that benzimidazole fungicides can be intensively 
absorbed on soil organic matter and imbibed by non-target plants leads to concerns about their 
adverse effects on treated plant crops (Goralczyk et al., 2005; Berglof et al., 2002). 
As far as the mammalian toxicity of benzimidazole fungicides, their metabolites and 
metabolic pathways is concerned, numerous studies were conducted. Since carbendazim is 
not only a parent “active” constituent of technical fungicide formulations, but also the 
metabolite of two other benzimidazole fungicides, namely benomyl and thiophanate-methyl, 
the data can be analyzed in detail and compared in these cases (EFSA, 2010b). 
The studies concerning mammalian toxicity of carbendazim showed that it is not acutely toxic 
and is not a skin/eye irritant, but is a skin sensitizer. Short-term toxicity studies performed on 
rats and dogs resulted in the increased liver weight, reduced testes weight, azoospermia, 
decreased body weight and lower food consumption. Carbendazim caused numerical 
chromosome aberrations (in vitro and in vivo) as a result of the interference with mitotic 
spindle proteins, but did not cause gene mutations or structural chromosomal aberrations. In 
long-term toxicity studies in rats, mice and dogs, increased liver weight was observed. 
Reproductive toxicity studies in rats showed that carbendazim produces infertility in males, 
decreased sperm counts, testicular atrophy and absence of spermatogenesis. Studies on 
developmental toxicity by oral gavage in rats and rabbits demonstrated that carbendazim is a 
developmental toxicant and a teratogen (EFSA, 2010b).  
Based on the effects described above, classification and labelling with R43 (may cause 
sensitisation by skin contact) in addition to the current classification and labelling as Mutagen 
Cat. 2 (R46) and Repr. Cat. 2 (R60-61) was proposed for carbendazim (EFSA, 2010b).  
As far as toxicity of carbendazim metabolites is concerned, one acute and one short term 
toxicity study with the metabolite 2-AB (2-aminobenzimidazole) were conducted (EFSA, 
2010b). 2-AB is formed by the cleavage of acetic acid of carbendazim and showed higher 
acute and equal short term toxicity compared to parent (EFSA, 2010b). 
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As mentioned before, carbendazim can be formed as a principal metabolite of other 
benzimidazole fungicides. It can originate from a fungicide benomyl (IUPAC name: methyl 
1-(butylcarbamoyl)benzimidazol-2-ylcarbamate) by the cleavage of the butylcarbamoyl side 
chain of parent. It can be also formed from thiophanate-methyl by the cleavage of the 
thioallophanate chain, cleavage of the sulphur and cyclisation to form the imidazole moiety 
(Figure 1). 
When the toxicity of carbendazim (as metabolite) is compared with the toxicity of the relevant 
precursors, the following conclusions may be drawn: (i) compared to Benomyl, carbendazim 
has equal acute toxicity, higher short and long term toxicity and equal reproductive and 
developmental toxicity; (ii) compared to thiophanate-methyl, carbendazim has equal acute 
and long term toxicity and higher short term, reproductive and developmental toxicity (EFSA, 
2010b).   
 
Figure 1. Carbendazim as a principal metabolite of benomyl and thiophanate-methyl 
As far as environmental fate and behaviour of carbendazim are concerned, EFSA identified 
lacking information on its route of aerobic degradation in soil and transformation products 
formed as a result of microbial activity in soil. As a consequence, the environmental exposure 
assessment for potential soil metabolites could not be finalised for the representative uses at 
EU level (EFSA, 2010d).  
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3. Simulating microbial metabolism of carbendazim with CRAFT 
3.1. CRAFT Explorer methodology and model details 
For the purpose of filling the gap in scientific data (EFSA, 2010d), the simulation of 
carbendazim biodegradation pathway was performed with the CRAFT (Chemical Reactivity 
and Fate Tool) Explorer v. 1.0 software, developed by Molecular Networks GmbH 
(http://www.molecular-networks.com/). CRAFT Explorer uses a knowledge base of different 
environmental reaction types derived from the University of Minnesota Biocatalysis and 
Biodegradation Database (UM-BBD, http://umbbd.msi.umn.edu/). The details of 
methodology underlying CRAFT Explorer predictions are described in the CRAFT Explorer 
user manual.  
Briefly, the evaluation of the chemical reactivity and fate of carbendazim was based on the 
simulated degradation pathway, including a set of degradation reactions that carbendazim 
undergoes and the set of imaginable products. CRAFT Explorer was used to generate all the 
conceivable reactions starting from the investigated molecule (i.e. carbendazim) up to a 
specified limit. The final reaction generation required preselection of three variables: (a) a 
likelihood model applicable to an evaluation; (b) stop criteria defining when the program 
should cancel any further degradation and (c) a likelihood threshold. 
The CRAFT Explorer likelihood models consist of several reaction rules, reaction types and 
likelihood categories assigned to each single rule. Reaction type is a general definition of a 
chemical transformation provided in the form of a reaction and annotated with the necessary 
substructure features and transformation definitions. Reaction rule implements certain 
reaction type and connects the general definition with the specific reaction conditions and 
likelihood estimations. From two likelihood models available in the software, namely the 
UM-BBD likelihood model and the ester hydrolysis sample model, the first one was selected. 
The UM-BBD likelihood model implements the biotransformation rules defined by Ellis et al. 
(2006) and available at the UM-BBD web site (http://umbbd.msi.umn.edu/). The reaction 
rules evaluated in the scope of UM-BBD likelihood model were considered for 
biodegradation under aerobic conditions, in soil (moderate moisture) or water, at neutral pH, 
in 25°C, with no competing or toxic other compounds 
(http://umbbd.msi.umn.edu/predict/rulepriority.html/). In the simulated biodegradation tree, 
the following model categories were assigned to every reaction rule to estimate the likelihood 
of each identified reaction type under the specified conditions : (i) very likely reaction, 
corresponding to the reactions that almost certainly occur and occur with the highest priority; 
(ii) likely reaction, used when almost all microbes can catalyze a given reaction with a 
functional group present in a molecule; (iii) neutral, applicable to reactions that are common 
but not certainly occur in each simulated system. Some reactions, for instance, which are 
generally quite possible, may or may not be likely to occur for each substrate and require 
individual investigation. Some reactions from “neutral” category may thus be “likely”, some 
may be “possible” and some may be “unlikely”, based on current knowledge. The likelihood 
thresholds for carbendazim biodegradation modelling were set (and colour coded) as follows: 
(i) 0 – 0.2 for very unlikely reactions (red); (ii) 0.3 – 0.4 for unlikely reactions (orange); (iii) 
0.5 – 0.6 for possible reactions (yellow for 0.5 and light green for 0.6); (iv) 0.7 – 0.8 for likely 
reactions (green) and (v) 0.9 – 1.0 for very likely reactions (dark green). 
Selection of the stop criteria finishing the simulation procedure performed by CRAFT 
Explorer and resulting in the amount of reactions and products generated required 
specification of the number of biodegradation steps, i.e. the number of levels of 
biodegradation, that will be considered by the software during the simulation procedure. 
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Increasing the number of the degradation steps increases the number of identified products 
since the procedure of submitting all molecules (i.e. products generated at each degradation 
level) is repeated. For the purpose of carbendazim biodegradation simulation the maximal 
number of steps (i.e. 5) was selected, in order to perform the modelling in the broadest 
possible sense.  
The last step before final biodegradation simulation was the selection of overall likelihood 
threshold. The overall likelihood of a reaction product can be defined, in terms of CRAFT 
Explorer, as a product of the likelihood of all the preceding products in the degradation tree 
(Figure 2).  
 
Figure 2. The CRAFT Explorer 1.0 overall likelihood threshold definition 
Selection of the overall likelihood threshold allows the generation of the less likely products 
by CRAFT to be reduced. The higher is the threshold, fewer products will be identified by the 
software. The threshold was set as 0.6, thus CRAFT Explorer has not generated products with 
the lower value of the overall likelihood. 
3.2. Carbendazim biodegradation tree  
Carbendazim biodegradation tree, along with the structures of generated products 
(metabolites), is visualised in Figure 3. The diagram shows the entire degradation pathway, 
including all degradation routes leading to each identified degradation product. The arrows 
indicate the single reactions and the colours indicate their likelihood. The structure of each 
generated molecule (starting with the query compound carbendazim situated at the top of the 
diagram) is represented in a box, located on the level corresponding to the level of 
biodegradation.  
The biodegradation pathway of carbendazim consists of 17 degradation steps leading to the 
formation of 15 various degradation products (P2 – P16). All metabolites are formed as a 
result of particular reaction types associated with particular UM-BBD reaction rules – the 
total amount of both, identified by CRAFT, was 7. The detailed list and description of 
reactions, along with “active” substructural fragments of given substrates, is given in Table 2. 
The overview of generated products is given in Table 3.  
In general, the most frequent reaction types, each leading to the formation of 4 various 
degradation products at different degradation levels were UM-BBD bt0005 (vic-unsubstituted 
aromatic ?  vic-dihydroxyaromatic) and UM-BBD bt0367 (vic-unsubstituted aromatic ?  vic-
dihydrodihydroxyaromatic), both connected with dioxygenation of vic-unsubstituted 
aromatics and subsequent oxidation, leading to the formation of catechol derivatives.  
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Figure 3. Carbendazim biodegradation tree simulated by CRAFT Explorer 1.0
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Table 2. Reaction rules and reaction types corresponding with particular structural alerts identified by CRAFT Explorer 1.0 during the 
simulation of carbendazim biodegradation pathway (UM-BBD, http://umbbd.msi.umn.edu/ ) 
 
No UM-BBD 
Reaction Rule 
Reaction Type Associated 
Structural Alert 
Comments 
1 UM-BBD 
bt0003 
Aldehyde ?  Carboxylate 
 
Likely reaction. 
 
 
2 UM-BBD 
bt0005 
vic-unsubstituted Aromatic 
?  vic-Dihydroxyaromatic 
 
 
 
 
Likely reaction. 
 
This rule handles the dioxygenation of vic-unsubstituted aromatics and 
subsequent oxidation to form the catechol derivative. When there is more 
than one potential site of dioxygenation, all possible positions are given. 
This rule acts on both cis and trans-dihydrodiol intermediates. The aromatic 
hydrocarbon dioxygenases produce an activated dioxygen species that is 
thought to be sufficiently reactive to potentially functionalize most aromatic 
ring carbon atoms. Commonly, the position of dioxygenation is determined 
by the orientation of the ring(s) in the enzyme's active site, which cannot be 
predicted. All fused aromatic ring products with hydroxyl at 2,3 position are 
excluded. This rule does not act on heterocyclic aromatic rings and many 
aromatic carboxylates. 
3 UM-BBD 
bt0023 
dialiphatic Ether ?  Alcohol 
+ Aldehyde 
 
Neutral reaction. 
 
This rule does not handle ethers when the vicinal carbons are halogenated. 
When given an aromatic aliphatic ether (Ar-O-R1) it will produce ArOH + 
R1CHO. When given a dialiphatic ether (R1-O-R2) it will produce both R1-
OH + R2 CHO and R2-OH + R1-CHO. It will not act on a diaromatic ether 
(Ar1-O-Ar2) or a ring ether. Rule is blocked from acting on CoA. 
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No UM-BBD 
Reaction Rule 
Reaction Type Associated 
Structural Alert 
Comments 
4 UM-BBD 
bt0065 
1-Amino-2-unsubstituted 
aromatic ?  vic-
Dihydroxyaromatic + Amine 
 
Neutral reaction. 
  
This rule also handles fused rings. All fused aromatic ring products with 
hydroxyl at 2,3 position are excluded. 
5 UM-BBD 
bt0318 
Carbamyl ?  Amine + 
Carbonate 
 
Likely reaction.  
6 UM-BBD 
bt0367 
vic-unsubstituted Aromatic 
?  vic-
Dihydrodihydroxyaromatic 
 
 
 
 
 
Likely reaction. 
  
This rule handles the dioxygenation of vic-unsubstituted aromatics and 
subsequent oxidation to form the catechol derivative. When there is more 
than one potential site of dioxygenation, all possible positions are given. 
This rule acts on both cis and trans-dihydrodiol intermediates. The aromatic 
hydrocarbon dioxygenases produce an activated dioxygen species that is 
thought to be sufficiently reactive to potentially functionalize most aromatic 
ring carbon atoms. Commonly, the position of dioxygenation is determined 
by the orientation of the ring(s) in the enzyme's active site, which cannot be 
predicted. All fused aromatic ring products with hydroxyl at 2,3 position are 
excluded. This rule does not act on heterocyclic aromatic rings and many 
aromatic carboxylates. 
7 UM-BBD 
bt0384 
mono Alkylcarbonate ?  
Alkyl 1-ol 
 
Very likely reaction. 
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Table 3. The overview of carbendazim biodegradation products simulated by CRAFT 
Explorer 1.0 
 
 
CRAFT ID: P2 
2-aminobenzimidazole (2-AB) 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: C=1C=CC=2NC(=NC=2(C=1))N 
CRAFT shortest pathway: 
Carbendazim ?  UM-BBD bt0318 ?  P2 
 
CRAFT ID: P3  
2-imino-2,3-dihydro-1H-benzimidazole-4,5 -diol 
CRAFT overall likelihood: 0.64 (Likely) 
SMILES: N=C1NC=2C=CC(O)C(O)C=2(N1) 
CRAFT shortest pathway: 
Carbendazim ?  UM-BBD bt0318 ?  P2 ?  UM-BBD 
bt0367 ?  P3 
 
CRAFT ID: P4  
2-imino-2,3-dihydro-1H-benzimidazole-5,6 -diol 
CRAFT overall likelihood: 0.64 (Likely) 
SMILES: N=C1NC2=CC(O)C(O)C=C2(N1) 
CRAFT shortest pathway: 
Carbendazim ?  UM-BBD bt0318 ?  P2 ?  UM-BBD 
bt0367 ?  P4 
 
CRAFT ID: P5  
2-AB-4,5-diol 
CRAFT overall likelihood: 0.64 (Likely) 
SMILES: OC=1C=CC=2NC(=NC=2(C=1(O)))N 
CRAFT shortest pathway: 
Carbendazim ?  UM-BBD bt0318 ?  P2 ?  UM-BBD 
bt0005 ?  P5 
 
CRAFT ID: P6 
2-AB-5,6-diol 
CRAFT overall likelihood: 0.64 (Likely) 
SMILES: OC1=CC=2N=C(N)NC=2(C=C1(O)) 
CRAFT shortest pathway: 
Carbendazim ?  UM-BBD bt0318 ?  P2 ?  UM-BBD 
bt0005 ?  P6 
 
CRAFT ID: P7 
Monomethyl carbonate 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: COC(=O)O 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0318 ?P7 
 
CRAFT ID: P8 
Methanol 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: CO 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0318 ?P7 ?  UM-BBD 
0384 ?  P8 
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CRAFT ID: P9 
Formaldehyde 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: C=O 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0023 ?P9 
 
CRAFT ID: P10 
Formic acid 
CRAFT overall likelihood: 0.64(Likely)  
SMILES: O=C[O-] 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0023 ?P9 ?  UM-BBD 
bt0003 ?  P10 
 
CRAFT ID: P11 
Methyl hydrogen (6,7-dihydroxy-6,7-dihydro-1H-
benzimidazol-2-yl)imidocarbonate 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: COC(O)=NC1=NC=2C=CC(O)C(O)C=2(N1) 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0367 ?P11 
 
CRAFT ID: P12 
Methyl hydrogen (6,7-dihydroxy-1H-benzimidazol -2-
yl)imidocarbonate 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: COC(O)=NC1=NC=2C=CC(O)=C(O)C=2(N1) 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0005 ?P12 
 
CRAFT ID: P13 
Methyl hydrogen (5,6-dihydroxy-5,6-dihydro-1H-
benzimidazol-2-yl)imidocarbonate 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: COC(O)=NC1=NC2=CC(O)C(O)C=C2(N1) 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0367 ?P13 
 
CRAFT ID: P14 
Methyl (5,6-dihydroxy-1H-benzimidazol-2-
yl)carbamate (5,6-DHCB) 
CRAFT overall likelihood: 0.80 (Likely) 
SMILES: COC(O)=NC1=NC2=CC(O)=C(O)C=C2(N1) 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0005 ?P14 
 
CRAFT ID: P15 
((E)-amino[(2,3-
dihydroxyphenyl)imino]methyl)carbamic acid 
CRAFT overall likelihood: 0.60 (Possible) 
SMILES: COC(=O)NC(=NC=1C=CC=C(O)C=1(O))N 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0065 ?P15 
 
CRAFT ID: P16 
1H-benzimidazol -2-ylcarbamic acid 
(2-Benzimidazolecar bamic acid) 
CRAFT overall likelihood: 0.60 (Possible) 
SMILES: O=C(O)NC1=NC=2C=CC=CC=2(N1) 
CRAFT shortest pathway: 
Carbendazim ? UM-BBD bt0023 ?P16 
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4. Simulating mammalian metabolism of carbendazim with Meteor 
4.1. Meteor methodology and model de tails 
The mammalian metabolic fate of a fungicide carbendazim was simulated by Meteor v. 12.0.0 
software tool of Lhasa Ltd. (https://www.lhasalimited.org/index.php/meteor/). The simulation 
was based on the expert knowledge rules in metabolism organised and stored in a knowledge 
base (database version used: Meteor12.0.0_14_08_2009). The query molecular structure of 
carbendazim was processed against biotransformations and reasoning rules from the Meteor 
knowledge base. The predictions were performed with respect to mammals and did not grow 
from metabolites issued from phase II biotransformations. The number of generated 
metabolites was limited (as default) to 400 and the maximum number of steps generated in 
any given pathway was 4. 
The procedure of generating carbendazim biotransformations consisted of three steps:  
(i) searching the knowledge database for biotransformations and populating a list of 
potential metabolites on the basis of carbendazim molecular structure;  
(ii) eliminating generated metabolites according to the absolute reasoning rules, which are 
based on factors such as observed rates of occurrence and yields in the literature, the 
physicochemical properties of the substrate (Log P and molecular weight) and whether 
a substrate is the query structure or a metabolite generated by Meteor, thereby 
selecting metabolites with a specified level of likelihood and compiling a shorter list 
of metabolites. The uncertainty terms used in Meteor in relation to predicted 
biotransformations and metabolites include: “probable” (when there is at least one 
strong argument that the proposition is true and there are no arguments against it), 
“plausible” (when the weight of evidence supports the proposition), “equivocal” 
(when there is an equal weight of evidence for and against the proposition), “doubted” 
(when the weight of evidence opposes the proposition) and “improbable” (when there 
is at least one strong argument that the proposition is false and there are no arguments 
that it is true). For the purpose of the present investigation, the “plausible” level of 
likelihood was selected (biotransformations adjudged to be at least plausible are 
displayed; 
(iii) eliminating more metabolites, according to the relative reasoning rules, by comparing 
competitive biotransformations and deciding which will take precedence. The relative 
reasoning included only the most likely (so-called “level 1”) biotransformations.  
On completion of the Meteor analysis, the knowledge base biotransformations matching the 
query structure were visualised in the form of a metabolic tree. 
4.2. Carbendazim metabolic tree 
The metabolic tree of carbendazim (Figure 4), presenting Meteor 12.0.0 simulation results, 
begins with the query structure (Q) situated at the top and followed by first generation 
metabolites (M1-M3) and, subsequently, by further generations of metabolites below their 
respective parents (M4). The tree visualises the whole pathway leading from carbendazim to 
metabolites via available biotrans formations. In the tree hierarchy the information on the 
likelihood levels, indicating the likelihood of the first and subsequent generation 
biotransformations occurring, is also provided and colour coded. 
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Figure 4. Carbendazim metabolic tree simulated by Meteor 12.0.0 
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Meteor 12.0.0 identified two types of phase I biotransformations that carbendazim undergoes 
inside mammalian organism, namely: the hydrolysis of carbamates and the hydroxylation of 
fused benzenes and one type of phase II biotransformation, namely the glucuronidation of 
aromatic alcohols. Each biotransformation was identified by a knowledge base reference 
number and name; the general overview of all of them is provided in Table 4. 
The hydrolysis of carbamates as well as the hydroxylation of fused benzenes were considered 
as reactions likely to occur in mammals. The generation of metabolites M1-M3 resulting from 
both phase I reaction types was estimated as “plausible”. This likelihood was assessed on the 
basis of carbendazim lipophilicity, according to general principles described by Testa & 
Cruciani (2001). It was also dependent on whether the considered molecule was an 
administered (query) compound (i.e. carbendazim in this case) or a metabolite generated by 
the software (Hutson, 1989). Phase I biotransformations #155 and #211 were estimated 
"plausible", as carbendazim was the substrate of medium lipophilicity (otherwise the 
likelihood associated with considered reactions would be "doubted") and was an administered 
(query) compound (if the substrate was a generated metabolite, the likelihood would be 
lower). 
Meteor gives an additional option to screen the intermediates in particular biotransformation 
reactions. For carbamate hydrolysis reaction two intermediates (namely isocyanate and 
carbamic acid) can be expressed and reported by the software (but they are not subjected to 
the effects of the reasoning engine or separate processing). Isocyanate belongs to “potentially 
adduct-forming” intermediates (Meteor type-a intermediates), due to its expected high 
electrophilicity. Carbamic acid is additionally labelled as “presumed” intermediate (Meteor 
type-ap), as it decarboxylates extremely rapidly, is difficult to characterise and is not expected 
to accumulate or be detected (Figure 5). 
 
 
Figure 5. Intermediates in hydrolysis of carbamates reaction given by Meteor 12.0.0 
 
As far as the hydroxylation of fused benzene compounds is concerned, N additional relative 
reasoning rule, stating that the reaction is more likely in the 2(3) position than in the 1(4) 
position, was applied during metabolite generation.  
The substructural fragments of carbendazim contributing to particular phase I reactions as 
well as the details (including names, SMILES strings and lipophilicity data) concerning all 
generated metabolites are provided in Table 5. 
As far as phase II biotransformation is concerned, one reaction type (glucuronidation of 
aromatic alcohols) was identified by Meteor 12.0.0. Its likelihood was considered purely 
dependent on the lipophilicity of the substrate according to general principles only (Testa & 
Cruciani, 2001) and was deemed independent of whether the substrate was an administered 
(query) compound or a generated metabolite. As the lipophilicity of M3 (a substrate in this 
case) was medium, the reaction was estimated as “plausible” (prominent phase II reactions 
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such as glucuronidation are typically considered as "probable" for substrates of high 
lipophilicity and "equivocal" for those of low lipophilicity) (Testa & Cruciani, 2001).  
Additionally (at the step of relative reasoning), the reaction of aromatic alcohols (phenols and 
heteroaromatic analogues) sulphation was considered as competitive to glucuronidation, but 
finally turned out to be less likely.  
The details concerning carbendazim phase II biotransformation and the resulting metabolite 
(M4) are presented in Table 6. 
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Table 4. The overview of carbendazim biotransformations predicted by Meteor 12.0.0 
 
Meteor 
Biotransformation No 
(Phase, enzyme) 
Biotransformation 
Name  
(Parent ?  Metabolite) 
 
Reaction 
General Comments 
(about the scope and limitations of the 
biotransformation) 
 
 
#155 
 
(Phase I, Hydrolase) 
 
Hydrolysis  
of  
Carbamates 
 
(Carbendazim ?  M1) 
(Carbendazim ?  M2) 
 
Hydrolysis of carbamate esters has been demonstrated for a 
fairly wide range of substrates.  In general the reaction is 
slower than for the corresponding carboxylic amide. 
 
 
 
#211 
 
(Phase I, CYP450) 
 
Hydroxylation  
of  
Fused Benzenes 
 
(Carbendazim ?  M3) 
 
 
Phenolic compounds are the most stable and frequently 
excreted products of aromatic ring hydroxylation mediated 
by cytochrome P450 enzymes (other products may be 
epoxides, dihydrodiols, catechols or quinones).  The 
mechanisms involved are complex and the product 
regioselectivity is difficult to predict. 
 
 
 
 
 
 
 
 
 
#027 
 
(Phase II, UGT) 
 
 
 
 
 
 
 
Glucuronidation  
of  
Aromatic Alcohols 
 
(M3 ?  M4) 
 
 
 
 
 
 
 
The formation of glucuronides from phenols is an important 
reaction in drug metabolism. The position of hydroxy groups 
relative to other ring substituents does not significantly affect 
conjugation.  Likewise, bulky ortho- (and di-ortho) 
substituents do not hinder conjugation in some species.  The 
donating coenzyme for the reaction is uridine-5'-diphospho-
alpha-D-glucuronic acid.  Glucuronic acid has the alpha-
configuration when bound in the coenzyme but has the beta-
configuration when bound as a glycone.  The carboxylic acid 
function in glucuronides has a pKa of 3.5 - 4.0 which means 
that they are essentially fully ionised in plasma and urine.  
The combined effects of the carboxylate anion and hydroxyl 
group account for the extreme polarity, lack of biological 
activity and ready urinary excretion of most glucuronides.  
High molecular weight glucuronides may enter an 
enterohepatic circulation pathway via biliary excretion and 
reversion to the aglycone through the action of gut 
microflora beta - glucuronidases. 
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Table 5. Phase I metabolites of carbendazim generated by Meteor 12.0.0 (structural alerts 
marked in red). Bt (Biotransformation) #155 refers to the hydrolysis of carbamates and #211 
to the hydroxylation of fused benzenes 
  
 
Parent molecule 
Meteor  
Bt Number 
(Enzyme) 
 
Metabolite 
N
N
O
O
N
H
H
H
H
H
H
H
H H
 
#155 
(Hydrolase) 
 
O
O
H
H
H
O
 
Q: Carbendazim (MCB) 
SMILES: 
c12c(cccc1)N=C(NC(=O)OC)N2 
Log P: 1.709 (from external data 
source used to calculate Log P) 
 M1: Monomethyl carbonate 
SMILES:  
COC(=O)O 
Log P: -0.869 (from external data source used to 
calculate Log P) 
N
N
O
O
N
H
H
H
H
H
H
H
H H
 
#155 
(Hydrolase) 
 
N
N
N
H
H
H
H
H H
 
Q: Carbendazim (MCB) 
SMILES: 
c12c(cccc1)N=C(NC(=O)OC)N2 
Log P: 1.709 (from external data 
source used to calculate Log P) 
 M2: 2-aminobenzimidazole (2-AB) 
SMILES:  
C=1C=CC=2NC(=NC=2(C=1))N 
Log P: 1.238 (from external data source used to 
calculate Log P) 
N
N
O
O
N
H
H
H
H
H
H
H
H H
 
#211 
 (CYP450) 
 
N
N
O
O
N
H
H
H
H
H
H
H H
O
 
Q: Carbendazim (MCB) 
SMILES: 
c12c(cccc1)N=C(NC(=O)OC)N2 
Log P: 1.709 (from external data 
source used to calculate Log P) 
 M3: Methyl (5-hydroxybenzimidazol-2-
yl)carbamate (5-HBC) 
SMILES:  
c12c(cc(O)cc1)N=C(NC(=O)OC)N2 
Log P: 1.757 (from external data source used to 
calculate Log P) 
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Table 6. Phase II metabolites of carbendazim generated by Meteor 12.0.0 (structural alerts 
marked in red). Bt (Biotransformation) #027 refers to the glucuronidation of aromatic 
alcohols 
  
 
Parent molecule 
Meteor  
Bt Number 
(Enzyme) 
 
Metabolite 
N
N
O
O
N
H
H
H
H
H
H
H H
O
 
#027  
(UGT) 
 
N
N
O
O
N
H
H
H
H
H
H
H
H
O
O
O
O
O
O
O
 
M3: Methyl (5-hydroxybenzimidazol-2-
yl)carbamate (5-HBC)  
SMILES: 
c12c(cc(O)cc1)N=C(NC(=O)OC)N2 
Log P: 1.757 (from external data source 
used to calculate Log P) 
 M4: Glucuronic acid conjugate of Methyl 5-hydroxy-1H-
benzimidazol-2-ylcarbamate  (5-HBC-G) 
SMILES: 
c12c(cc(OC3C(O)C(O)C(O)C(C(=O)O)O3)cc1)N=C(NC(=O)OC)N2 
Log P: -0.547 (from external data source used to calculate Log P) 
 
 
 
 
 20 
5. Predicting carbendazim metabolites with the QSAR Application Toolbox 
Two metabolism simulators (microbial and liver mammalian) are implemented in the OECD 
QSAR Application Toolbox 2.0 (beta version). The microbial metabolism simulator is based 
on the original CATABOL simulator (Dimitrov et al., 2004; Dimitrov et al., 2002; Jaworska 
et al., 2002). The liver mammalian metabolism simulator is based on the methodology applied 
in OASIS TIMES (Tissue Metabolism Simulator) software. CATABOL and TIMES are 
developed and marketed by the Laboratory of Mathematical Chemistry (http://www.oasis-
lmc.org/?section=software/). 
The publicly available OECD QSAR Application Toolbox does not provide insights into the 
detailed maps of microbial/mammalian biotransformations, which is possible in the original 
(commercial) models. Nevertheless, both simulators allow the user to predict the sets of 
possible metabolites, resulting either from microbial activity or from biotransformation 
reactions occurring in the liver of different mammals. In this study, the simulation of 
metabolites by the OECD software was used for comparative purposes. 
The simulations were performed on the basis of experimental data, stored in two databases: (i) 
"observed microbial catabolism" database, including information on aerobic catabolism for 
200 diverse chemicals (C1-compounds, aliphatic hydrocarbons, alicyclic rings, furans, 
halogenated hydrocarbons, aromatic hydrocarbons and haloaromatics, amines, sulphonates, 
nitrates, nitro-derivatives, nitriles and compounds containing more than one functional group) 
and compiled from scientific literature as well as publicly available databases, e.g. the 
University of Minnesota Biocatalysis and Biodegradation Database (Ellis et al., 2006); (ii) 
"observed mammalian metabolism" database including documented in vivo and in vitro 
information on metabolic pathways in mammalian microsomes for 200 diverse chemicals 
(including chemicals with various functionalities, aliphatic hydrocarbons, alicyclic rings, 
furans, halogenated hydrocarbons, aromatic hydrocarbons and haloaromatics, amines, 
sulphonates, nitrates, nitro-derivatives), also retrieved from scientific publications and public 
web sites.  
The details of methodology implemented in both simulators are described in detail in the 
original CATABOL (Dimitrov et al., 2004; Dimitrov et al., 2002; Jaworska et al., 2002) and 
TIMES (Mekenyan et al., 2004) papers. For the purpose of populating the reasonable number 
of metabolites, the software settings were kept as default, i.e.: (i) for microbial metabolism 
only the first level of biodegradation with transformations having minimal probability of 
0.001 was simulated; (ii) for mammalian liver metabolism 5 levels of biodegradation and 
reactions with the minimal probability equal 0.7 were considered. These constrains were 
suggested by the developers, as relating the simulators with the reality in the best way, and 
were based on experts knowledge as well as available experimental data.  
The microbial metabolism simulation resulted in the formation of 18 potential carbendazim 
degradation products (Table 7). As far as liver metabolism of carbendazim is concerned, the 
OECD software provided a set of 8 metabolites (Table 8). The results were highly dependent 
on the user constraints. For instance, changing the thresholds for microbial metabolism 
simulation and considering 5 degradation levels with minimal probability of each reaction 
equal 0.6 (as in CRAFT Explorer) resulted in the generation of 813 different carbendazim 
degradation products.  
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Table 7. Microbial metabolites of carbendazim predicted by the OECD QSAR Application 
Toolbox 2.0 (beta version) 
# Metabolite # Metabolite # Metabolite 
1 
N
NH
O
HO
NH
 
c12c(cccc1)N=C(NC(=O)O)N2 
1H-benzimidazol-2-ylcarbamic acid 
(2-Benzimidazolecarbamic acid) 
7 
OH NH
OH
 
c1(O)c(NCO)cccc1 
2-[(hydroxymethyl)amino] 
phenol 
13 
O
OH
 
C(=O)O 
Formic acid 
2 
H3C
OH
 
CO 
Methanol 
8 
OH OH
 
c1(O)c(O)cccc1 
Catechol 
14 
O
OH
O
CH2
 
C(=O)(O)C(=O)CC=C 
2-oxopent-4-enoic acid 
3 
N
NH2
NH
 
c12c(cccc1)N=C(N)N2 
2-aminobenzimidazole 
(2-AB) 
9 
NH2
OH
 
C(N)O 
Aminomethanol 
15 
O
OH
O
CH3
OH
 
C(=O)(O)C(=O)CC(C)O 
4-hydroxy-2-oxopentanoic 
acid 
4 
NNH
 
c12c(cccc1)N=CN2 
Benzimidazole 
10 
H2C
O
 
C=O 
Formaldehyde 
16 
O
OHCH3
O
 
C(=O)(O)C(C)=O 
Pyruvic acid 
(2-oxopropanoic acid) 
5 
OH N
NH2
 
c1(O)c(N=CN)cccc1 
N'-(2-hydroxyphenyl) 
imidoformamide 
11 
O
OH
OH
O
 
C(=O)(O)C(O)=CC=CC=O 
2-hydroxy-6-oxohexa-2,4-
dienoic acid 
17 
CH3
O
 
C(C)=O 
Acetaldehyde 
6 
OH N CH2
 
c1(O)c(N=C)cccc1 
2-(methylideneamino) 
phenol 
12 
O
OH
OH
CH2
 
C(=O)(O)C(O)=CC=C 
2-hydroxy-2,4-
pentadienoic acid 
18 
CH3
O
OH
 
C(C)(=O)O 
Acetic acid 
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Table 8. Liver mammalian metabolites of carbendazim predicted by the OECD QSAR 
Application Toolbox 2.0 (beta version) 
  
# Metabolite  # Metabolite  
1 
OH
N
NHO
O
CH3
NH
 
c12c(cc(O)cc1)N=C(NC(=O)OC)N2 
5-HBC 
5 
OH
N
NH2
NH
 
c12c(cc(O)cc1)N=C(N)N2 
2-aminobenzimidazol-5-ol 
2 
N
NH
O
HO
NH
 
c12c(cccc1)N=C(NC(=O)O)N2 
1H-benzimidazol-2-ylcarbamic acid 
(2-Benzimidazolecarbamic acid) 
6 
N
NH
OH
NH
 
c12c(cccc1)N=C(NO)N2 
N-hydroxy-1H-benzimidazol-2-
amine 
3 
H3C OH
 
 
CO 
Methanol 
7 
OH
NH
NH2N
 
c1(O)c2c(ccc1)NC(N)=N2 
2-aminobenzimidazol-4-ol 
4 
N
NH2
NH
 
c12c(cccc1)N=C(N)N2 
2-aminobenzimidazol (2-AB) 
8 
OH
N
NH2NH
 
 
c1(O)c2c(ccc1)N=C(N)N2 
2-aminobenzimidazol-7-ol 
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6. Discussion and conclusions 
6.1. Biodegradation of carbendazim 
It is difficult to evaluate the results of the biodegradation simulations with CRAFT and the 
QSAR Application Toolbox, due to the paucity of experimental data. According to the scarce 
information available in the scientific literature, carbendazim is decomposed in the 
environment with half- lives of 6 to 12 months in bare soil, 3 to 6 months in turf, and half- lives 
in water of 2 and 25 months under aerobic and anaerobic conditions, respectively. The major 
microbial metabolism product is 2-aminobenzimidazole (2-AB), which undergoes further 
biodegradation (Figure 6). Another possible degradation product suggested is 1,2-
diaminobenzene (JMPR, 1999), this was however not predicted by any of the applied 
software. 
 
 
Figure 6.  Biodegradation pathway of carbendazim suggested in the literature (JMPR, 1999) 
 
Both software tools, namely CRAFT Explorer 1.0 and OECD QSAR Application Toolbox, 
predicted 2-AB as a major compound formed due to microbial activity and the possible 
products of its subsequent decomposition (e.g. CRAFT P3, P4, P5, P6, all being "diol" 
derivatives). At the same time, both tools identified many more products that could 
theoretically be generated (depending on the reaction conditions), as illustrated in tables 3 and 
7.  
In the context of a chemical risk assessment, the CRAFT predictions, suggesting the main 
biodegradation routes and products of carbendazim, could be used to guide further 
investigations. It is not possible to conclude whether the simulated information is adequate to 
fill current data gaps (e.g. concerning the aerobic biodegradation of carbendazim in soil), 
since ultimately this is a policy decision. The simulations do however raise a number of 
questions that should be considered when judging adequacy in a regulatory context, such as:  
a) how constrained the simulation should be;  
b) how much substantiating evidence should be available (for example, there may be 
partial evidence for the occurrence of certain degradates / metabolites);  
c) how to supplement the metabolite information with (predicted) toxicological profiles 
(for example, using QSAR prediction tools). 
 
6.2. Mammalian metabolism of carbendazim 
In contrast to biodegradation, extensive data on mammalian metabolic pathways for 
carbendazim are available in the literature (Figure 7). The metabolism of carbendazim has 
been studied in rats, mice, rabbits, dogs, sheep and cows. The basic biotransformation route 
involves hydroxylation with the major metabolite, being methyl 5-hydroxybenzimidazol-2-
ylcarbamate (5-HBC), and the minor one, being methyl 5,6-dihydroxybenzimidazol-2-
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ylcarbamate (5,6-DHCB). The hydroxylated metabolites appear to readily form excretable 
sulphate and glucuronide conjugates (JMPR, 1999). A small amount of 5,6-HOBC N-oxide 
(mainly as the glucuronide) was also identified. In mammalian organisms detoxification also 
proceeds through hydrolysis, leading to the formation of 2-aminobenzimidazole (2-AB) as the 
main metabolite (JMPR, 1999).  
A detailed comparison of the metabolites predicted by Meteor 12.0.0 and the OECD QSAR 
Application Toolbox with the metabolites identified experimentally is provided in Table 9. 
At the first sight, many discrepancies between the observed and simulated biotransformations 
are noticeable. However, a more in-depth investigation reveals that the differences are not so 
significant and depend mainly on the constraints defined by the software user. Since Meteor 
was used to predict the metabolic routes/metabolites formed with at least the “plausible” level 
of likelihood, it identified only the major product of carbendazim hydroxylation (i.e. 5-HBC) 
and did not predict the minor metabolite (5,6-DHBC). For the same reason, the metabolite (5-
HBC-G) resulting from 5-HCB glucuronidation (Bt_exp_03) was predicted, whereas the 
alternative product (5-HBC-S) resulting from competing sulphation reaction (Bt_exp_02) was 
not predicted, since this reaction did not meet the “plausible” level of likelihood criteria.  
For comparative purposes, the mammalian metabolism of carbendazim was simulated with 
different initial Meteor settings. First, the minimal level of likelihood was changed from 
"plausible" to "equivocal" and the "global (breadth first search)" option was selected. The 
simulation resulted in the prediction of 323 different metabolites, resulting not only from the 
biotransformations identified in the original simulation (i.e. hydrolysis of carbamates, 
hydroxylation of fused benzenes and glucuronidation of aromatic alcohols), but also from 
other reactions, e.g. N-oxidation at aromatic nitrogen (i.e. Meteor bt #347), being "equivocal" 
and leading to the formation of metabolite identified experimentally (i.e. 5,6-HOBC-N-oxide). 
In the second alternative simulation, selection of at least the "equivocal" level of likelihood 
and the "one-at-time (depth first search)" option allowed to identify metabolites such as 5,6-
DHBC (formed due to aromatic ring hydroxylation via arene oxides, i.e. Meteor bt #81) and 
5,6-DHBC-S (resulting from O-sulphation of aromatic alcohols, i.e. Meteor bt #20). In other 
words, the results of the metabolic simulation are strictly dependent on the software settings 
specified by the user, which therefore have to be chosen carefully and in relation to the 
purpose of investigation.  
The mammalian metabolites generated by the OECD QSAR Application Toolbox resulted 
mainly from two metabolic reactions: hydrolysis and hydroxylation of carbendazim, leading 
to the formation of 2-AB and 5-HBC, respectively. The metabolites were subsequently 
transformed into: (i) methanol and 1H-benzimidazol-2-ylcarbamic acid, due to further 
hydrolysis of 5-HBC and (ii) a hydroxylated amine (N-hydroxy-1H-benzimidazol-2-amine) 
and some aromatic alcohols (2-AB-5-ol, 2-AB-4-ol, 2-AB-7-ol) due to the hydroxylation of 2-
AB. 
 
6.3. Parallels between microbial biodegradation and mammalian metabolism  
As far as the parallels between microbial biodegradation and mammalian metabolism are 
concerned, in all cases (i.e. in silico and experimental data) hydrolysis and hydroxylation 
were the most important reactions. All software tools identified the major carbendazim 
metabolite, 2-aminobenzimidazole (2-AB), which has higher acute toxicity than the parent 
compound (not acutely toxic). Numerous hydroxylation products, either of the parent 
molecule or of the formed (intermediate) metabolites, were identified by the three software 
tools, which is in agreement with experimental data on carbendazim mammalian metabolism.  
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Figure 7. Experimentally documented metabolic pathways of carbendazim in rats (JMPR, 
1999) 
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6.4. General conclusions and recommendations  
It is important to be aware that there is no unique set of predictions by most metabolic 
simulation tools. By changing the model constraints, the user has numerous possibilities to 
simulate the generation pathways and metabolites, according to the purpose of investigation. 
For example, only the most probable and significant reactions could be simulated, in which 
case only a limited amount of major metabolites will be predicted. Alternatively, all 
imaginable (theoretically possible) biotransformations could be simulated, including those 
that are highly unlikely to occur under real environmental/biological conditions. Both CRAFT 
Explorer and Meteor evaluate the probabilities of forming particular metabolites, giving the 
possibility to expand or restrict the scope of in silico simulation, depending on the purpose of 
the investigation. For example, it might be necessary to identify only the major metabolites, 
or only the toxicologically relevant metabolites. Both software tools give an insightful 
interpretation and reasoning of the results and specify the types of competitive reactions 
considered during simulation. This, in turn, gives the user a rational basis for refining the 
predictions. Being aware of the reactions neglected by the software (as less probable), the user 
can apply his/her own knowledge to decide whether the skipped biotransformations should 
also be taken into account. If the aim of the exercise is to identify toxicologically relevant 
metabolites, the results of the metabolism simulation can be considered in conjunction with 
the known or predicted (eco)toxicological properties of the metabolites. To facilitate this 
process, Meteor provides an integrated interface with the Lhasa Ltd expert system software, 
Derek for Windows (DfW), which makes predictions for a a wide range of ecotoxicological 
and toxicological effects. A wide range of other prediction tools can also be used to generate 
toxicological profiles for the metabolites, as reviewed elsewhere (Fuart-Gatnik & Worth, 
2010). These profiles can be compared with the toxicological profiles of the parent 
compound, perhaps in the context of a TTC approach, to assess whether any toxicologically 
relevant metabolite is associated with a lower TTC than the parent compound. The 
applicability of these concepts have been explored in a series of EFSA-funded studies (EFSA 
2010a, 2010b, 2010c), and further work is ongoing under the auspices of an EFSA Working 
Group on the Relevance of Pesticide Metabolites to develop practical guidance on how to 
apply the concepts in regulatory practice. This is an important initiative, which goes beyond 
the use of computational methods. For example, one issue being considered is what 
distinguishes a major from a minor metabolite, and how this may depend on the context 
(whether the metabolite is present in rodents, plants or livestock). Guidance on the 
interpretation of computer-simulated metabolism is also needed in other areas of regulatory 
decision making (e.g. industrial chemicals, biocides, cosmetics). 
In general, it is concluded that: 
(i) rule-based metabolism simulators open great possibilities to obtain extensive 
information on the biotransformation routes of chemicals in different species and 
under different environmental conditions; 
(ii) expertise is needed in the use metabolism simulators, in particular by setting the 
appropriate scope of simulation; 
(iii) expertise is also needed to interpret the results of the simulation, according to the 
purpose of the investigation, and taking into account available (corroborating) data 
(iv)  further efforts are needed to develop guidance on the interpretation of simulated 
metabolic pathways and reaction products in the context of environmental and 
human health risk assessments performed for regulatory purposes. For example, in 
relation to pesticide risk assessment, there is a need to use methods that provide 
quantitative or semi-quantitative indicators of the amounts of metabolites formed, 
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and the timecourses of metabolite generation, in mammals, birds, livestock and 
plants as well as in the environment. It is also useful to be able to compare the 
main metabolic pathways in the different species and conditions). 
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Table 9. Comparison of mammalian metabolites predicted by Meteor and the QSAR Application Toolbox with documented experimental data 
(the major observed routes of biotransformation are marked in bold green; NA – not applicable; * - microbial metabolites identified by CRAFT)  
 
Experimental 
Biotransformation No. 
(Fig. 5) (JMPR, 1999) 
 
Type of Reaction 
Observed 
(Experimental) 
Metabolite  
 
Predicted by Meteor 12.0.0? 
Predicted by the QSAR 
Application Toolbox? 
Bt_exp_01 Hydroxylation of Carbendazim 5-HBC Plausible Yes 
Bt_exp_02 Sulphation of 5-HCB 5-HBC-S In original simulation considered as competitive reaction, 
but less probable than Bt_exp_03. Predicted as "equivocal" 
in alternative simulation with different settings (and lower 
minimal level of likelihood).  
No 
Bt_exp_03 Glucuronidation of 5-HCB 5-HBC-G Plausible No 
Bt_exp_04 Hydroxylation of Carbendazim 5,6-DHBC* Predicted as "equivocal" in alternative simulation with 
different settings (and lower minimal level of likelihood). 
No 
Bt_exp_05 N-Oxidation of 5,6-DHCB 5,6-HOBC-N-oxide Predicted as "equivocal" in alternative simulation with 
different settings (and lower minimal level of likelihood). 
No 
Bt_exp_06 O-Sulphation of 5,6-DHCB 5,6-DHBC-S Predicted as "equivocal" in alternative simulation with 
different settings (and lower minimal level of likelihood). 
No 
Bt_exp_07 Glucuronidation of 5,6-DHCB 5-DHCB-G Predicted as "equivocal" in alternative simulation with 
different settings (and lower minimal level of likelihood). 
No 
Bt_exp_08 Glucuronidation of 5,6-HOBC-N-oxide 5,6-HOBC-N-oxide-G Predicted as "equivocal" in alternative simulation with 
different settings (and lower minimal level of likelihood). 
No 
Bt_exp_09 Conjugation of with gluthatione 5,6-DHHBC-G Predicted as "equivocal" in alternative simulation with 
different settings (and lower minimal level of likelihood). 
No 
Bt_exp_10 Hydrolysis of Carbendazim 2-AB* Plausible Yes 
Not detected (Hydrolysis of Carbendazim) Monomethyl carbonate* Plausible  NA 
Not detected (Hydrolysis of 5-HBC) Methanol* NA Yes 
Not detected (Hydrolysis of 5-HBC) 1H-benzimidazol-2-
ylcarbamic acid* 
NA Yes 
Not detected (Hydroxylation of 2-AB) N-hydroxy -1H-
benzimidazol-2-amine 
NA Yes 
Not detected (Hydroxylation of 2-AB) 2-AB-4-ol; 2-AB-5-ol; 2-
AB-7-ol 
NA Yes 
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Abstract 
 
A major source of uncertainty when assessing the human health and environmental risks of chemicals is the 
paucity of experimental information on the metabolic and (bio)degradation pathways of parent compounds and 
the toxicological properties of their metabolites and (bio)degradation products. Taking into account animal 
welfare and cost-effectiveness considerations, the only practical means of obtaining the information needed to 
reduce this uncertainty, is to use alternative (non-animal) methods, such as in vitro tests and in silico models. 
  
In this report, we explore the usefulness of in silico metabolic simulation tools (expert systems) as a means of 
supporting the regulatory assessment of chemicals. In particular, we investigate the use of selected in silico 
tools to: (i) simulate microbial and mammalian metabolic pathways; (ii) identify potential metabolites resulting 
from biotransformation; and (iii) gain insights into the mechanistic rationale of simulated metabolic reactions and 
the likelihood of their occurrence. For illustrative purposes, the microbial and mammalian biotransformation 
pathways of a case study compound, the fungicide carbendazim, were generated by using the CRAFT Explorer 
1.0 (Molecular Networks GmbH) and Meteor 12.0.0 (Lhasa Ltd.) software tools. Additionally, the set of potential 
metabolites resulting from microbial and mammalian metabolism was predicted with the OECD QSAR 
Application Toolbox 2.0 (beta version).  
 
Comparison of the in silico predictions with existing experimental data on carbendazim metabolism showed the 
potential usefulness of using software tools for metabolite prediction. However, the results are strongly 
dependent on the software constraints specified by the user, and require careful interpretation, taking into 
account the needs of the exercise and the availability of existing information. Further efforts are needed to 
develop guidance on the use of in silico metabolic simulation tools for the purposes of regulatory risk 
assessments. 
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